PCSK9 Inhibitors: New Jersey
A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in New Jersey from January 2017 through December 2017. Of health plans that received at least 200 claims for PCSK9 inhibitors, the following had the highest rates of rejections: • Horizon BCBS NJ – 62% • Express Scripts – 41% • United Health […]
PCSK9 Inhibitors: Mississippi
A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in Mississippi from January 2017 through December 2017. Of health plans that received at least 50 claims for PCSK9 inhibitors, the following had the highest rates of rejections: • BCBS Mississippi – 97% • State of Mississippi Employees – 94% • Express Scripts […]
PCSK9 Inhibitors: Indiana
A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in Indiana from January 2017 through December 2017. Of health plans that received at least 150 claims for PCSK9 inhibitors, the following had the highest rates of rejections: • Anthem – 58% • Express Scripts – 42% • MDwise – 37% • CVS […]
PCSK9 Inhibitors: Illinois
A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in Illinois from January 2017 through December 2017. Of health plans that received at least 150 claims for PCSK9 inhibitors, the following had the highest rates of rejections: • Express Scripts – 40% • CVS Health – 31% • United Health Group – […]
PCSK9 Inhibitors: Georgia
A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in Georgia from January 2017 through December 2017. Of health plans that received at least 200 claims for PCSK9 inhibitors, the following had the highest rates of rejections: • Anthem – 80% • Georgia State Health Benefit Plan – 54% • Tricare Military […]
PCSK9 Inhibitors: Arkansas
A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in Arkansas from January 2017 through December 2017. Of health plans that received at least 50 claims for PCSK9 inhibitors, the following had the highest rates of rejections: • Arkansas State Employees – 95% • BCBS AR – 60% • Express Scripts – […]
